Tag: Cancer: Lung
Primary, Pulmonary Providers Endorse Lung CA Screening
Key barriers to LCS include inadequate time and staffing, patients having too many illnesses
Checkpoint Inhibitors No Less Safe With Radiation
Combination does not increase immune-related adverse events in metastatic lung cancer patients
Accurate Lung Cancer Staging Depends on Quality Nodal Exam
Difference in exam thoroughness may account for large regional differences in survival
ASTRO: SBRT Prolongs Survival in Non-Small-Cell Lung Cancer
Trial stopped after significant improvement in progression-free survival in metastatic NSCLC
ASTRO: Standard-Dose CRT Beats Higher Dose in Stage III NSCLC
Significantly improved five-year overall survival rates with 60 Gy chemoradiation tx versus high-dose
Expected Burden of Lung Cancer High for People Living With HIV
PLWH who adhere to antiretroviral tx but smoke are substantially more likely to die from lung cancer
Longer Progression-Free Survival for Durvalumab in NSCLC
Longer median progression-free survival from randomization, higher response rate with durvalumab
Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men
Increased odds only seemed to affect men or male smokers
Total, Saturated Fat Linked to Increased Risk of Lung Cancer
Pooled analysis shows substitution with polyunsaturated fat reduces risk of carcinoma
Nivolumab Doesn’t Up PFS in Stage IV or Recurrent NSCLC
Findings in patients with previously untreated disease with PD-L1 expression level of ≥5 percent
